Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overactive bladder pharmacotherapy: what does the future hold?

Roger R Dmochowski1

  • 1Department of Urologic Surgery, Vanderbilt Continence Center, Vanderbilt University School of Medicine, Nashville, TN, USA. roger.dmochowski@vanderbilt.edu

BJU International
|May 10, 2007
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urobiome Analysis in Interstitial Cystitis/Bladder Pain Syndrome Reveals Nuanced Differences Associated with Localized Pain.

International urogynecology journal·2026
Same author

Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.

Minerva urology and nephrology·2026
Same author

Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective.

Journal of medical economics·2026
Same author

Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study.

The Journal of urology·2026
Same author

Impact of Revi® Implantable Tibial Neuromodulation on Quality of Life in Patients with Urgency Urinary Incontinence.

International urogynecology journal·2026
Same author

Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder.

Journal of comparative effectiveness research·2025
Same journal

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

BJU international·2026
Same journal

Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC.

BJU international·2026
Same journal

A call for regimen agnostic circulating tumour DNA-guided adjuvant selection in muscle-invasive bladder cancer.

BJU international·2026
Same journal

Ablative radiotherapy in castration-resistant prostate cancer.

BJU international·2026
Same journal

Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.

BJU international·2026
Same journal

Venous thromboembolism after penile cancer surgery: a UK PeCaN study.

BJU international·2026
See all related articles